Species-Dependent Mechanisms of Cardiac Arrhythmia: A Cellular Focus
- PMID: 28469490
- PMCID: PMC5392019
- DOI: 10.1177/1179546816686061
Species-Dependent Mechanisms of Cardiac Arrhythmia: A Cellular Focus
Abstract
Although ventricular arrhythmia remains a leading cause of morbidity and mortality, available antiarrhythmic drugs have limited efficacy. Disappointing progress in the development of novel, clinically relevant antiarrhythmic agents may partly be attributed to discrepancies between humans and animal models used in preclinical testing. However, such differences are at present difficult to predict, requiring improved understanding of arrhythmia mechanisms across species. To this end, we presently review interspecies similarities and differences in fundamental cardiomyocyte electrophysiology and current understanding of the mechanisms underlying the generation of afterdepolarizations and reentry. We specifically highlight patent shortcomings in small rodents to reproduce cellular and tissue-level arrhythmia substrate believed to be critical in human ventricle. Despite greater ease of translation from larger animal models, discrepancies remain and interpretation can be complicated by incomplete knowledge of human ventricular physiology due to low availability of explanted tissue. We therefore point to the benefits of mathematical modeling as a translational bridge to understanding and treating human arrhythmia.
Keywords: arrhythmia; cardiomyocyte; electrophysiology; species.
Conflict of interest statement
DECLARATION OF CONFLICTING INTERESTS: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Myerburg RJ, Mitrani R, Interian A, Castellanos A. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation. 1998;97:1514–1521. - PubMed
-
- Waring MJ, Arrowsmith J, Leach AR, et al. An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat Rev Drug Discov. 2015;14:475–486. - PubMed
-
- Hamlin RL. Animal models of ventricular arrhythmias. Pharmacol Ther. 2007;113:276–295. - PubMed
-
- Sanguinetti MC, Bennett PB. Antiarrhythmic drug target choices and screening. Circ Res. 2003;93:491–499. - PubMed
-
- Dorian P, Newman D. Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview. Europace. 2000;2:277–285. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
